Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancer.
about
Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Loss of NR2E3 represses AHR by ...... oor prognosis in liver cancer.
@en
type
label
Loss of NR2E3 represses AHR by ...... oor prognosis in liver cancer.
@en
prefLabel
Loss of NR2E3 represses AHR by ...... oor prognosis in liver cancer.
@en
P2093
P2860
P1433
P1476
Loss of NR2E3 represses AHR by ...... oor prognosis in liver cancer.
@en
P2093
Jiang Wang
Kwangmin Choi
Kyounghyun Kim
Shuk-Mei Ho
Sung-Gook Cho
Tilak Khanal
Vinothini Janakiram
P2860
P2888
P356
10.1038/S41598-017-11106-2
P407
P577
2017-09-06T00:00:00Z